Revolutionary Chinese Medicinal Fungus Promises Hope for Chronic Lung Disease Sufferers
Potential Breakthrough in Treating Idiopathic Pulmonary Fibrosis with Traditional Chinese Medicinal Fungus
New Delhi, July 26: A recent study suggests that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, may offer a new avenue for treating idiopathic pulmonary fibrosis (IPF) – a severe lung disease marked by scarring and stiffness. Conducted on mice, the research underscores the fungus’s potential to alleviate symptoms and enhance lung function.
IPF is a chronic, progressive condition characterized by deteriorating lung function, leading to respiratory failure and severely diminished quality of life. The disease often proves fatal, with a median survival range of just 2 to 5 years post-diagnosis. Current treatments, primarily antifibrotic medications, come with significant side effects, highlighting the pressing need for more effective alternatives.
Led by the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences, the research demonstrated that Cordyceps sinensis, renowned for its antioxidant and anti-inflammatory properties, can reduce lung inflammation and collagen buildup in mice. These findings, published in the journal MedComm-Future Medicine, suggest that the therapeutic benefits of the fungus may stem from its regulation of mitochondrial oxidative phosphorylation – a potential protective mechanism against IPF.
Specifically, Cordyceps sinensis was shown to lower the production of mitochondrial reactive oxygen species (mitROS), thereby reducing oxidative stress and inflammation. These processes collectively contribute to the fungus’s therapeutic effects in combating pulmonary fibrosis, offering hope for a more effective treatment for patients afflicted by this debilitating disease.
"Cordyceps sinensis has the potential to be a novel therapeutic agent for IPF, with its effects validated through both in vivo and in vitro experiments," state the researchers. However, they emphasize the necessity for further studies to pinpoint the specific components responsible for its therapeutic impact and to thoroughly understand its detailed mechanisms of action.
As research continues, Cordyceps sinensis appears to be a promising candidate in the ongoing quest to find a more effective, less harmful treatment for idiopathic pulmonary fibrosis.
Original Story https://assamtribune.com/health-and-fitness/this-chinese-medicinal-fungus-may-help-treat-chronic-lung-disease-1545488
Category : Health & Fitness,More
Tags:
